Why the share price has tanked
in response to
by
posted on
Jul 13, 2008 07:30AM
Commercialization of protein-based vaccines & biopharmaceuticals
On July 14th, 2008, MDG has the 13 million shares from it's previous $.20 PP become free trading. It appears somone jumped the gun, locked in profits by shorting the stock down at higher prices and will cover when their PP shares become free trading. Apparently this is the way investors do things these days, with the current state of the stock market.
Now the market will be flooded by 13 million shares hitting the market all at the same time. To keep the stocks share price up over $.20 will require someone to buy up these shares before the stock can realistically even think of going to higher levels. Personally I will not be selling any of my PP shares until at least the start of the Phase One human trials, expected late in 2008 or very early 2009.
As countries start to plan ahead, just in case of a breakout of the bird flu panademic. MDG will most likely get a huge cash infusion, from one or more countries to lock up the availability of vaccines for their populations. This stock has huge potential for early investors as the story unfolds. However, one or two more PP's to get MDG's share price to the next level is probable. MDG is obviously not suitable for anyone with a short term investor mentality.
It is my belief anyone who buys in at current share prices will do very well going forward. But, it will require patience, so don't look for instant wealth on this investment. JMHO
Al